FMR1 and fragile X syndrome: In contrast, the FMR1 locus remains hypermethylated in induced pluripotent stem (iPS) cell lines derived from FXS patients, suggesting that, once the methylation marks are established at this locus, they are stable and resistant to current reprograming methodologies [10].